EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases

Eine Disproportionalitätsanalyse von durch GnRHas verursachten unerwünschten Ereignissen aus den FAERS- und JADER-Datenbanken

Shupeng Zou, Mengling Ouyang, Yazheng Zhao, Qian Cheng, Xuan Shi, Minghui Sun

Frontiers in Pharmacology · 04.07.2024 · 15

DOI: 10.3389/fphar.2024.1392914 ↗

Auf einen Blick

Die Analyse von FAERS und JADER zeigte für GnRHas mehrere verdächtige unerwünschte Ereignisse und Unterschiede zwischen den Datenbanken. Für Leuprorelin, Triptorelin und Goserelin wurden auch neue Signale beschrieben.

Fragestellung

Welche unerwünschten Ereignisse sind in FAERS und JADER mit GnRHas assoziiert?

Methode

Disproportionalitätsanalyse mit zwei adjustierten Algorithmen in FAERS und JADER von 2004 bis 2023; klinische Priorisierung, Analyse schwerer/nicht schwerer Verläufe und Onset-Zeiten.

Ergebnisse

FAERS/JADER: 50.360.413 und 1.440.200 AEs. Verdächtige PTs: Leuprorelin 562, Goserelin 189, Triptorelin 172, Leuprorelin-JADER 85. Medianer Onset: 23, 22 und 217 Tage.

Schlussfolgerung der Autor:innen

Die Untersuchung zweier Datenbanken zeigte verdächtige AEs im Zusammenhang mit GnRHas. Die Autoren sehen potenzielle neue AE-Signale und empfehlen weitere klinische Überwachung und Studien.

Kernaussagen

  • Leuprorelin hatte die meisten verdächtigen PTs.
  • Zwischen FAERS und JADER zeigten sich Unterschiede in Signalstärken.
  • Medianer Onset: Leuprorelin 23 Tage, Triptorelin 22 Tage, Goserelin 217 Tage.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.07.2024. Verfasst von Shupeng Zou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gonadotrophin-releasing hormone analogs (GnRHas) play a significant role in addressing gynecological diseases, central precocious puberty, and cancer. However, ensuring the safety of GnRHas in real-world applications requires continuous vigilance. In light of this, we undertook a disproportionality analysis focused on adverse events (AEs) associated with GnRHas using data from both the FDA Adverse Event Reporting System (FAERS) and the Japanese Adverse Drug Event Report (JADER). We evaluated GnRHas-associated AEs and characterized the clinical priority of unlisted AEs caused by each GnRHa from the different databases.

Methods

In the disproportionality analysis, we applied two adjusted algorithms to identify signals related to GnRHas in the FAERS and JADER databases from 2004 to 2023. Additionally, we utilized the Statistical Analysis System (SAS, 9.4) to examine potential and high-aROR (adjusted reporting odds ratio) signals associated with GnRHas. We performed clinical priority assessment for suspicious PTs and an analysis of serious/non-serious outcomes. We also gathered information on the onset times of AEs linked with GnRHas from both databases.

Results

From January 2004 to September 2023, FAERS and JADER recorded a total of 50,360,413 and 1,440,200 AEs, respectively. Employing two algorithms, the suspicious preferred terms (PTs) related to leuprolide (Leu) were 562 potential PTs (44 unlisted in specifications), followed by goserelin (Gos) with 189 PTs (28 unlisted), triptorelin (Tri) with 172 PTs (28 unlisted), and Leu-JADER with 85 PTs (10 unlisted). At the same PT level, the differences in GnRHas between the two databases were observed, such as cardiac failure, diabetes mellitus, liver disorder, dementia, suicidal ideation, interstitial lung disease, urinary disorders, and hypertensive crisis. In an analysis of serious vs. non-serious outcomes, a total of 43 AEs of Leu were more likely to be reported as serious AEs with p < 0.05 (such as asthenia, urinary retention, diabetes mellitus, interstitial lung disease, gait disturbance, and so on), following by Tri (6 AEs), and Gos (4 AEs). Based on the clinical priority score, 41 PTs of Leu, 26 PTs of Tri, 24 PTs of Gos, and 8 PTs of Leu-JADER were graded as weak. There were 3 PTs of Leu, 2 PTs of Tri, 4 PTs of Gos, and 2 PTs of Leu-JADER that were graded as moderate. Notably, in the assessment of the relevant evidence, 2 PTs (loss of libido and urinary tract toxicity caused by Leu), 1 PT (electrolyte imbalance caused by Tri), and 2 PTs (anorexia and suicidal ideation caused by Gos) showed a strong level of evidence with “++.” The differences in the signal strength of the same PTs from two databases were also worth noting. Moreover, the median onset time for GnRHas (Leu, Tri, and Gos) was 23 days (0, 298), 22 days (0, 181), and 217 days (29, 706), respectively, as median (Q1, Q3).

Conclusion

An examination of two databases revealed suspicious AEs associated with GnRHas. Our study found potential new AE signals of GnRHas and supported continuous clinical monitoring, pharmacovigilance, regional differences, and further studies of GnRHas.

Schlagwörter

Stichwörter der Autor:innen

FAERSGnRHasJADERadverse eventsdata mining

Autor:innen und Institutionen

  • Department of Pharmacy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Zitieren

APA

Zou, S., Ouyang, M., Zhao, Y., Cheng, Q., Shi, X., & Sun, M. (2024). A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1392914

Vancouver

Zou S, Ouyang M, Zhao Y, Cheng Q, Shi X, Sun M. A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1392914

BibTeX
@article{Zou2024,
  author = {Zou, Shupeng and Ouyang, Mengling and Zhao, Yazheng and Cheng, Qian and Shi, Xuan and Sun, Minghui},
  title = {A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1392914}
}
Kostenlos starten →